Amphastar Pharmaceuticals (AMPH) Asset Utilization Ratio (2014 - 2026)

Amphastar Pharmaceuticals' Asset Utilization Ratio history runs 13 years deep, the most recent figure standing at 0.44 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 3.6% year-over-year to 0.44; the TTM figure through Mar 2026 stood at 0.44 (down 3.6% YoY), while the FY2025 annual figure was 0.45, down 5.22% from the prior year.
• Asset Utilization Ratio was 0.44 for Q1 2026 at Amphastar Pharmaceuticals, up from 0.44 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.68 in Q1 2023 to a low of 0.41 in Q3 2023.
• Historically, Asset Utilization Ratio has averaged 0.51 across 5 years, with a median of 0.47 in 2024.
• The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio sank 38.46% in 2023, then increased 15.82% in 2024.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.68 in 2022, then sank by 37.97% to 0.42 in 2023, then climbed by 11.22% to 0.47 in 2024, then slipped by 6.81% to 0.44 in 2025, then advanced by 0.64% to 0.44 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.44 (Q1 2026), 0.44 (Q4 2025), and 0.44 (Q3 2025), per Business Quant data.